JNJ — Johnson & Johnson stock price and chart

JNJ

Johnson & JohnsonStock · HealthcareDow Jones 2.8% · S&P 500 0.9% · Russell 1000 0.9% · US Stock Market 0.8% · Russell 3000 0.8% · MSCI World 0.6% · MSCI ACWI 0.6% · S&P 500 Equal Weight 0.2%

$265.58-0.29%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHMRKABBVAMGN

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

120.0140.0160.0180.0200.0220.0240.0260.00200.0M400.0M$265.58

2026-09-11

Price$265.58

MA20$246.07

MA50$218.51

Vol33.8M

What would $1,000 invested in JNJ be worth today? →

JNJ returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $265.58
Change YTD: +30.39%
Next earnings: Oct 13, 2026 · Before open
Market cap: 640B2016-09 323.2B2026-09 640B+98.0% over the window
Enterprise value: 669.7B
Shares outstanding: 2.4B2016-07 2.7B2026-06 2.4B-11.9% over the window
52W low: $173.33
52W high: $281.07
From 52W high: -5.51%
From 52W low: +53.22%
52W range: 86%
Beta: 0.24

Volume

Rel volume: 0.69×
30D volume: 6.4M
30D $ vol: 1.7B

Fundamentals

Sales (ttm): 97.9B2017-01 71.9B2026-06 97.9B+36.2% over the window
Sales/share: $40.642017-01 $26.492026-06 $40.64+53.4% over the window
EPS (ttm): $8.622016-07 $5.372026-06 $8.62+60.6% over the window
FCF (ttm): 22.2B2016-07 14.4B2026-06 22.2B+54.2% over the window
FCF/share: $9.232016-07 $5.272026-06 $9.23+75.0% over the window
Book value/share: $35.262016-07 $26.492026-06 $35.26+33.1% over the window
Net margin: 21.48%2017-01 23.0%2026-06 21.5%-6.6% over the window
ROE: 24.76%2016-07 20.7%2026-06 24.8%+19.4% over the window
ROA: 10.46%2016-07 10.7%2026-06 10.5%-2.7% over the window
Debt / equity: 0.44×2016-07 0.342026-06 0.44+29.8% over the window
Current ratio: 1.092016-07 3.082026-06 1.09-64.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: +8.09%2025-06-29 → 2026-06-2890.6B → 97.9B (+8.1% total)+5.97%2023-07-02 → 2026-06-2882.3B → 97.9B (+18.9% total)+1.89%2021-07-04 → 2026-06-2889.2B → 97.9B (+9.8% total)+3.31%2017-01-01 → 2026-06-2871.9B → 97.9B (+36.2% total)
Net income: -7.19%2025-06-29 → 2026-06-2822.7B → 21B (-7.2% total)+17.31%2023-07-02 → 2026-06-2813.1B → 21B (+61.2% total)+3.45%2021-07-04 → 2026-06-2817.8B → 21B (+18.4% total)+3.43%2016-07-03 → 2026-06-2815B → 21B (+40.0% total)
FCF: +20.00%2025-06-29 → 2026-06-2818.5B → 22.2B (+19.9% total)+15.26%2023-07-02 → 2026-06-2814.5B → 22.2B (+52.9% total)-0.29%2021-07-04 → 2026-06-2822.6B → 22.2B (-1.4% total)+4.43%2016-07-03 → 2026-06-2814.4B → 22.2B (+54.2% total)
Shares: +0.06%2025-06-29 → 2026-06-282.4B → 2.4B (+0.1% total)-2.49%2023-07-02 → 2026-06-282.6B → 2.4B (-7.3% total)-1.76%2021-07-04 → 2026-06-282.6B → 2.4B (-8.5% total)-1.26%2016-07-03 → 2026-06-282.7B → 2.4B (-11.9% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: -7.74%2025-06-29 → 2026-06-28$9.34 → $8.62 (-7.7% total)+20.49%2023-07-02 → 2026-06-28$4.94 → $8.62 (+74.6% total)+5.35%2021-07-04 → 2026-06-28$6.65 → $8.62 (+29.7% total)+4.86%2016-07-03 → 2026-06-28$5.37 → $8.62 (+60.6% total)
Sales/share: +8.02%2025-06-29 → 2026-06-28$37.63 → $40.64 (+8.0% total)+8.68%2023-07-02 → 2026-06-28$31.68 → $40.64 (+28.3% total)+3.72%2021-07-04 → 2026-06-28$33.88 → $40.64 (+19.9% total)+4.61%2017-01-01 → 2026-06-28$26.49 → $40.64 (+53.4% total)
FCF/share: +19.92%2025-06-29 → 2026-06-28$7.70 → $9.23 (+19.8% total)+18.21%2023-07-02 → 2026-06-28$5.60 → $9.23 (+64.9% total)+1.50%2021-07-04 → 2026-06-28$8.57 → $9.23 (+7.7% total)+5.77%2016-07-03 → 2026-06-28$5.27 → $9.23 (+75.0% total)
Book value/share: +8.24%2025-06-29 → 2026-06-28$32.58 → $35.26 (+8.2% total)+6.86%2023-07-02 → 2026-06-28$28.91 → $35.26 (+21.9% total)+5.95%2021-07-04 → 2026-06-28$26.43 → $35.26 (+33.4% total)+2.91%2016-07-03 → 2026-06-28$26.49 → $35.26 (+33.1% total)
Dividend/share: +4.40%2025-06-29 → 2026-06-28$5.02 → $5.24 (+4.4% total)+4.61%2023-07-02 → 2026-06-28$4.58 → $5.24 (+14.4% total)+5.10%2021-07-04 → 2026-06-28$4.09 → $5.24 (+28.1% total)+5.57%2016-07-03 → 2026-06-28$3.05 → $5.24 (+71.8% total)
Price: +48.82%2025-09-11 → 2026-09-11$178.50 → $265.58 (+48.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+17.75%2023-09-11 → 2026-09-11$162.66 → $265.58 (+63.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+9.72%2021-09-10 → 2026-09-11$166.97 → $265.58 (+59.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+8.43%2016-09-09 → 2026-09-11$118.23 → $265.58 (+124.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +52.18%2025-09-11 → 2026-09-11$174.57 → $265.58 (+52.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+21.14%2023-09-11 → 2026-09-11$149.37 → $265.58 (+77.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+12.83%2021-09-10 → 2026-09-11$145.21 → $265.58 (+82.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+11.41%2016-09-09 → 2026-09-11$90.08 → $265.58 (+194.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 30.8×2016-09 21.512026-09 30.42+41.5% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 29.4×2016-09 14.852026-09 29.40+98.0% over the window
Fwd P/E: 21.8×
P/S (ttm)Market cap ÷ TTM revenue.: 6.5×2017-03 4.702026-09 6.54+39.0% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 7.5×2016-09 4.462026-09 7.53+68.9% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 28.8×2016-09 22.402026-09 28.77+28.4% over the window
EV/EBITDA (fy): 19.7×
EV/Sales (ttm): 6.8×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 3.48%2016-07 4.5%2026-06 3.6%-19.4% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 1.97%
Dividend/share (fwd): $5.24
Buyback yield (realized, 1y)1 − shares_at(2026-06-28) ÷ shares_at(2025-06-29) = 1 − 2.41B ÷ 2.41B. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.06%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.06%) + dividends paid over that year ($12.6B) ÷ market_cap_at(2025-06-29) ($366.7B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 3.38%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($8.1B) ÷ today's market cap ($640B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 1.26%2016-07 2.1%2026-06 1.3%-39.2% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $8.1B + TTM dividends $12.6B) ÷ today's market cap ($640B). Same caveat as the cash buyback yield.: 3.23%2016-07 4.8%2026-06 3.3%-29.6% over the window

Vs own 10Y history

P/E: 84th
P/OI: 99th
P/S: 98th
P/B: 99th
P/FCF: 94th

Bar = where today’s multiple sits in JNJ’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

-0.29%

-4.62%

+2.31%

+11.98%

YTD

+30.39%

+54.48%

+74.57%

Financial statements

Open full JNJ financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%
ABT	Abbott Laboratories	-8.08%	-1.36%

Johnson & Johnson (JNJ) trades at $265.58 with a live price and an interactive chart covering 56+ years of daily price history, plus key valuation metrics. ChartRow also publishes JNJ’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full JNJ financial statements →

JNJ — Johnson & Johnson price, chart and key statistics